Physician profile
Brady Kurt Mock
NPI 1841630183
$8,185.88
in general payments reported to CMS, 2019-2025
14 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,945 · 2020: $1,374 · 2021: $525 · 2022: $182 · 2023: $861 · 2024: $182 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $749 · Food and Beverage: $411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $749.00 |
| Food and Beverage | $410.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,551.69 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $1,598.65 | 2019-2024 | Avenir, Persona |
| Medical Device Business Services, INC. | $1,318.57 | 2019 | |
| Lima USA, INC. | $171.37 | 2019 | |
| Smith+Nephew, INC. | $147.67 | 2022 | |
| Heraeus Medical, LLC. | $115.95 | 2019 | |
| Depuy Synthes Sales INC. | $97.68 | 2021-2024 | |
| Encore Medical, LP | $74.80 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $34.64 | 2025 | Exparel |
| Medtronic, INC. | $22.25 | 2022 | |
| Boston Scientific Corporation | $17.66 | 2020 | |
| Bioventus LLC | $16.22 | 2019 | |
| Avanos Medical | $11.50 | 2019 | |
| Orthofix Medical, INC. | $7.23 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brady Mock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.